These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12549535)

  • 1. The Australian Institute of Health and Welfare.
    Fitzsimmons GJ; Sadkowsky KR
    Commun Dis Intell Q Rep; 2002; 26(4):605-7. PubMed ID: 12549535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing national health information in Australia.
    Moss EA
    Medinfo; 1995; 8 Pt 2():1636. PubMed ID: 8591522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report from the Communicable Diseases Network Australia, January to March 2004.
    Commun Dis Intell Q Rep; 2004; 28(2):277-8. PubMed ID: 15460971
    [No Abstract]   [Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Australia's National Notifiable Disease Surveillance System.
    Miller M; Roche P; Spencer J; Deeble M
    Commun Dis Intell Q Rep; 2004; 28(3):311-23. PubMed ID: 15574055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An historical overview of Australia's largest and oldest provider of vocational rehabilitation--CRS Australia.
    O'Halloran D
    Work; 2002; 19(3):211-8. PubMed ID: 12547966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The National Reference Centres and Reference Laboratories. Importance and tasks].
    Laude G; Ammon A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):998-1004. PubMed ID: 16160887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relations between the Higher Institute of Health and regional and infraregional agencies].
    De Cesare G
    Ann Ist Super Sanita; 1985; 21(2):179-80. PubMed ID: 3832996
    [No Abstract]   [Full Text] [Related]  

  • 10. Privacy protection: implications for public health researchers.
    Lane MJ
    Med J Aust; 1991 Dec 2-16; 155(11-12):831-3. PubMed ID: 11652181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information management in national tuberculosis control programmes and national health information systems.
    Trébucq A; Aït-Khaled N; Gninafon M; Louis JP
    Int J Tuberc Lung Dis; 1998 Oct; 2(10):852-6. PubMed ID: 9783534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surveillance of communicable diseases in Europe; more than just a means of communication among national institutes].
    Verbrugh HA
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2388-90. PubMed ID: 9864532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Institute of Health Surveillance: from data collection to health alerts. Interview by Corinne Taeron].
    Brücker G
    Rev Infirm; 2003 Jan; (87):25-6. PubMed ID: 12677900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals in Australia: developments in regulation and governance.
    Lofgren H; Boer Rd
    Soc Sci Med; 2004 Jun; 58(12):2397-407. PubMed ID: 15081192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communicable diseases surveillance.
    Commun Dis Intell Q Rep; 2002; 26(4):608-30. PubMed ID: 12549536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Higher Institute of Health and international organizations].
    Toti L
    Ann Ist Super Sanita; 1985; 21(2):181-5. PubMed ID: 3832997
    [No Abstract]   [Full Text] [Related]  

  • 18. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Australia's National Medicines Policy using geographical mapping.
    Roughead EE; Monteith GR; Harvey KJ; Tett SE
    Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Expenditure Data, Analysis and Policy Relevance in Australia, 1967 to 2020.
    Goss JR
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.